Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Sequer
    replied
    Thee is no substitute for asking the research subject on their consent form what they might want back

    Leave a comment:


  • Incidental Findings via Next Gen Sequencing in Human Subject Research

    In a recent New York Times article by science writer Gina Kolata,

    "Genes now tell secrets they can't utter"



    the ease and affordability of human genome sequencing is targeted as the source of growing ethical quandries. One such trouble is what to do about significant incidental findings. It is my opinion that the blame can be placed on investigators relying on human subject consent forms from another era as well as Institutional Review Boards that continue to maintain technology-blind approaches ill serving genomic advances in the clinic.

    My suggestions to deal with the ethical issues of significant incidental findings center on reporting back results to a patient's referring primary care physician (many studies gain subjects through a referring physician whom the patients trusts). For those entering studies without a primary or referring physician, each study program should provide for an "incidental findings primary care doctor" who would meet with the subject to deliver and discuss findings of note.

    Yes, both my proposals involve communicating genetic findings back to a research subject through a doctor--not in line with the do-it-yourself, over the counter movement, I'm afraid. But human subject clinical research is not a population field-study project, however genetic the research question may be. Relying on subject anonymity (however this is stated or consented to by the subject) is an unacceptable ethical short cut and a detriment to the obligations involved in human subject research under ethical conditions.

Latest Articles

Collapse

  • seqadmin
    Multiomics Techniques Advancing Disease Research
    by seqadmin


    New and advanced multiomics tools and technologies have opened new avenues of research and markedly enhanced various disciplines such as disease research and precision medicine1. The practice of merging diverse data from various ‘omes increasingly provides a more holistic understanding of biological systems. As Maddison Masaeli, Co-Founder and CEO at Deepcell, aptly noted, “You can't explain biology in its complex form with one modality.”

    A major leap in the field has
    ...
    02-08-2024, 06:33 AM
  • seqadmin
    The 3D Genome: New Technologies and Emerging Insights
    by seqadmin


    The study of three-dimensional (3D) genomics explores the spatial structure of genomes and their role in processes like gene expression and DNA replication. By employing innovative technologies, researchers can study these arrangements to discover their role in various biological processes. Scientists continue to find new ways in which the organization of DNA is involved in processes like development1 and disease2.

    Basic Organization and Structure
    Understanding...
    01-22-2024, 03:25 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Today, 08:57 AM
0 responses
11 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-14-2024, 09:19 AM
0 responses
42 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-12-2024, 03:37 PM
0 responses
406 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-09-2024, 03:36 PM
0 responses
647 views
0 likes
Last Post seqadmin  
Working...
X